N-Nitroso Ruxolitinib

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ruxolitinib is in a class of medications called kinase inhibitors. It works to treat myelofibrosis and PV by blocking the signals that cause cancer cells to multiply. This helps to stop the spread of cancer cells. It works to treat GVHD by blocking the signals of the cells that cause GVHD. Ruxolitinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso Ruxolitinib  or Ruxolitinib Nitroso Impurity 1 CAS NO;NA Chemically  represented as (R)-3-cyclopentyl-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile . Synchemia is the leading manufacturing and  exporter of N-Nitroso Ruxolitinib or Ruxolitinib Nitroso Impurity 1.We supply Ruxolitinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.